PTC Therapeutics (PTCT) Interest Coverage Ratio: History & Chart

PTC Therapeutics, Inc.(PTCT)

Biotechnology · Warren, NJ

$63.93+0.28 (+0.45%)

Delayed quote: Oct 6, 2026, 2:15 PM EDT

About PTC Therapeutics, Inc.

PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a primary focus on addressing various rare disease indications. Among its commercialized products, PTC Therapeutics provides Translarna and Emflaza, offering therapeutic options for Duchenne muscular dystrophy patients in the European Economic Area and the United States. Translarna also addresses nonsense mutation Duchenne muscular dystrophy in Brazil and Russia. The company additionally commercializes Tegsedi and Waylivra for various rare conditions throughout Latin America and the Caribbean. Furthermore, in Brazil, PTC Therapeutics distributes Evrysdi as a treatment for spinal muscular atrophy (SMA) in patients aged two months and older. Leveraging its proprietary splicing platform, the company is also actively developing PTC518, a promising therapeutic candidate aimed at treating Huntington's disease. To bolster its research and development capabilities, PTC Therapeutics has established strategic collaborations, including partnerships with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation, focusing on advancing drug discovery and development research, particularly in regenerative medicine. Additionally, it collaborates with Akcea Therapeutics, Inc. for the commercialization of Tegsedi and Waylivra in the Latin America and Caribbean region. Established in 1998, PTC Therapeutics, Inc. maintains its corporate headquarters in South Plainfield, New Jersey.

Warren, NJ

991 employees

www.ptcbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Matthew Klein

View full financials

PTCT Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

5.63x

INTEREST COVERAGE RATIO AVG TTM

0.29x

INTEREST COVERAGE RATIO AVG 3Y

-0.61x

INTEREST COVERAGE RATIO AVG 5Y

-2.67x

INTEREST COVERAGE RATIO AVG 10Y

-6.33x

INTEREST COVERAGE RATIO AVG 15Y

-9.56x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+1813.93%

CURRENT VS 3Y AVG

+1023.03%

CURRENT VS 5Y AVG

+311.00%

CURRENT VS 10Y AVG

+188.91%

CURRENT VS 15Y AVG

+158.87%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-6.38x

median of 528 covered companies

CURRENT VS SECTOR MEDIAN

+188.31%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
PTC Therapeutics, Inc. (PTCT)	$5.34B	5.63x	0.29x	-0.61x	-2.67x
Doximity, Inc. (DOCS)vs ›	$5.28B	N/A	N/A	N/A	N/A
CRISPR Therapeutics AG (CRSP)vs ›	$5.27B	N/A	N/A	N/A	N/A
Sotera Health Company (SHC)vs ›	$5.24B	2.52x	2.17x	2.34x	2.30x
Cogent Biosciences, Inc. (COGT)vs ›	$5.17B	-108.87x	N/A	N/A	N/A
MiniMed Group, Inc. Common Stock (MMED)vs ›	$5.50B	N/A	N/A	N/A	N/A
Travere Therapeutics, Inc. (TVTX)vs ›	$5.17B	-5.85x	N/A	N/A	N/A
RadNet, Inc. (RDNT)vs ›	$5.53B	1.30x	1.31x	1.26x	1.25x
Merit Medical Systems, Inc. (MMSI)vs ›	$5.06B	6.97x	5.98x	8.44x	9.07x
Scholar Rock Holding Corporation (SRRK)vs ›	$5.07B	-55.80x	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

PTC Therapeutics, Inc. (PTCT)

$5.34B

5.63x

0.29x

-0.61x

-2.67x

Doximity, Inc. (DOCS)vs ›

$5.28B

N/A

CRISPR Therapeutics AG (CRSP)vs ›

$5.27B

N/A

Sotera Health Company (SHC)vs ›

$5.24B

2.52x

2.17x

2.34x

2.30x

Cogent Biosciences, Inc. (COGT)vs ›

$5.17B

-108.87x

N/A

MiniMed Group, Inc. Common Stock (MMED)vs ›

$5.50B

N/A

Travere Therapeutics, Inc. (TVTX)vs ›

$5.17B

-5.85x

N/A

RadNet, Inc. (RDNT)vs ›

$5.53B

1.30x

1.31x

1.26x

1.25x

Merit Medical Systems, Inc. (MMSI)vs ›

$5.06B

6.97x

5.98x

8.44x

9.07x

Scholar Rock Holding Corporation (SRRK)vs ›

$5.07B

-55.80x

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for PTC Therapeutics, Inc. (PTCT)?

The interest coverage ratio for PTCT stock is 5.63x.

Is PTC Therapeutics, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 5.63x is 311% above its 5-year average of -2.67x, around the middle of its 5-year range (-8.18x–28.46x).

What is the TTM average interest coverage ratio for PTC Therapeutics, Inc. (PTCT)?

The TTM average interest coverage ratio for PTCT stock is 0.29x.

What is the 3Y average interest coverage ratio for PTC Therapeutics, Inc. (PTCT)?

The 3Y average interest coverage ratio for PTCT stock is -0.61x.

What is the 5Y average interest coverage ratio for PTC Therapeutics, Inc. (PTCT)?

The 5Y average interest coverage ratio for PTCT stock is -2.67x.

What is the 10Y average interest coverage ratio for PTC Therapeutics, Inc. (PTCT)?

The 10Y average interest coverage ratio for PTCT stock is -6.33x.

What is the 15Y average interest coverage ratio for PTC Therapeutics, Inc. (PTCT)?

The 15Y average interest coverage ratio for PTCT stock is -9.56x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	3.07x
2026-03-31	0.94x
2025-12-31	-1.48x
2025-09-30	0.09x
2025-06-30	-1.15x
2025-03-31	28.46x
2024-12-31	-3.95x
2024-09-30	-1.31x
2024-06-30	-0.92x
2024-03-31	-1.11x
2023-12-31	0.07x
2023-09-30	-4.20x
2023-06-30	-7.12x
2023-03-31	-4.30x
2022-12-31	-8.18x
2022-09-30	-3.52x
2022-06-30	-4.20x
2022-03-31	-3.68x
2021-12-31	-3.77x
2021-09-30	-4.27x
2021-06-30	-4.37x
2021-03-31	-5.12x
2020-12-31	-3.97x
2020-09-30	-2.62x
2020-06-30	-34.82x
2020-03-31	-16.48x
2019-12-31	-13.32x
2019-09-30	-22.68x
2019-06-30	-18.69x
2019-03-31	-30.22x
2018-12-31	-13.90x
2018-09-30	-15.47x
2018-06-30	-1.93x
2018-03-31	-5.07x
2017-12-31	1.58x
2017-09-30	-9.03x
2017-06-30	-4.15x
2017-03-31	-11.88x
2016-12-31	-11.75x
2016-09-30	-15.03x
2016-06-30	-17.75x
2016-03-31	-19.65x
2015-12-31	-19.00x
2015-09-30	-49.57x
2014-12-31	-27.31x
2014-09-30	-77.97x
2013-09-30	-0.16x
2013-06-30	-126.59x
2013-03-31	-1.39x
2012-12-31	-29.87x
2012-09-30	-28.53x
2012-06-30	-22.38x
2012-03-31	-14.63x

DATE

INTEREST COVERAGE RATIO

2026-06-30

3.07x

2026-03-31

0.94x

2025-12-31

-1.48x

2025-09-30

0.09x

2025-06-30

-1.15x

2025-03-31

28.46x

2024-12-31

-3.95x

2024-09-30

-1.31x

2024-06-30

-0.92x

2024-03-31

-1.11x

2023-12-31

0.07x

2023-09-30

-4.20x

2023-06-30

-7.12x

2023-03-31

-4.30x

2022-12-31

-8.18x

2022-09-30

-3.52x

2022-06-30

-4.20x

2022-03-31

-3.68x

2021-12-31

-3.77x

2021-09-30

-4.27x

2021-06-30

-4.37x

2021-03-31

-5.12x

2020-12-31

-3.97x

2020-09-30

-2.62x

2020-06-30

-34.82x

2020-03-31

-16.48x

2019-12-31

-13.32x

2019-09-30

-22.68x

2019-06-30

-18.69x

2019-03-31

-30.22x

2018-12-31

-13.90x

2018-09-30

-15.47x

2018-06-30

-1.93x

2018-03-31

-5.07x

2017-12-31

1.58x

2017-09-30

-9.03x

2017-06-30

-4.15x

2017-03-31

-11.88x

2016-12-31

-11.75x

2016-09-30

-15.03x

2016-06-30

-17.75x

2016-03-31

-19.65x

2015-12-31

-19.00x

2015-09-30

-49.57x

2014-12-31

-27.31x

2014-09-30

-77.97x

2013-09-30

-0.16x

2013-06-30

-126.59x

2013-03-31

-1.39x

2012-12-31

-29.87x

2012-09-30

-28.53x

2012-06-30

-22.38x

2012-03-31

-14.63x

Interest Coverage Ratio: 5.63x

PTCT Interest Coverage Ratio

PTCT Average Interest Coverage Ratio Chart

PTCT Current vs Average Interest Coverage Ratio Chart

PTCT Interest Coverage Ratio Metrics

PTCT Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

PTCT Interest Coverage Ratio History

Related Metrics